The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma

The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma

This project will target patients with histopathologically diagnosed mucosal melanoma using [¹⁸F]FDG PET/CT imaging for retrospective prognostic evaluation.The primary objective is to explore the value of [¹⁸F]FDG PET/CT imaging in the prognostic assessment of mucosal melanoma, and to determine the correlations between quantitative [¹⁸F]FDG PET parameters and progression-free survival (PFS) as well as overall survival (OS), so as to provide reference evidence for individualized treatment decision-making.

Inclusion Criteria:

1. Patients with histopathologically confirmed mucosal melanoma.

Exclusion Criteria:

1. Having another primary malignancy (other than mucosal melanoma).
2. Being lost to follow-up.
3. Being under 18 years of age.
4. Being pregnant or breastfeeding.